Amanda J. Edson

Amanda J. Edson

Auto-generated profile, based on publicly available information

Amanda J. Edson

Department of Molecular Biology, University of Bergen, Bergen, Norway

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in Redox Biology
Verified
Journal Article
Open access
Javier EgeaJavier Egea
Javier Egea
Isabel FabregatIsabel Fabregat
Isabel Fabregat
YFYves M. Frapart
Yves M. Frapart
PGPietro Ghezzi
Pietro Ghezzi
AGAgnes Görlach
Agnes Görlach
Andreas DaiberAndreas Daiber
Andreas Daiber
The European Cooperation in Science and Technology (COST) provides an ideal framework to establish multi-disciplinary research networks. COST Action BM1203 (EU-ROS) represents a consortium of researchers from different disciplines who are dedicated to providing new insights and tools for better understanding redox biology and medicine and, in the long run, to finding new therapeutic strategies to target dysregulated redox processes in various diseases. This report highlights the major achievements of EU-ROS as well as research updates and new perspectives arising from its members. The EU-ROS consortium comprised more than 140 active members who worked together for four years on the topics briefly described below. The formation of reactive oxygen and nitrogen species (RONS) is an established hallmark of our aerobic environment and metabolism but RONS also act as messengers via redox regulation of essential cellular processes. The fact that many diseases have been found to be associated with oxidative stress established the theory of oxidative stress as a trigger of diseases that can be corrected by antioxidant therapy. However, while experimental studies support this thesis, clinical studies still generate controversial results, due to complex pathophysiology of oxidative stress in humans. For future improvement of antioxidant therapy and better understanding of redox-associated disease progression detailed knowledge on the sources and targets of RONS formation and discrimination of their detrimental or beneficial roles is required. In order to advance this important area of biology and medicine, highly synergistic approaches combining a variety of diverse and contrasting disciplines are needed.

1 June 2018 in Redox Biology
Verified
Journal Article
Open access
AFAnn Kristin Frøyset
Ann Kristin Frøyset
AEAmanda J. Edson
Amanda J. Edson
NGNaouel Gharbi
Naouel Gharbi
EKEssa A. Khan
Essa A. Khan
DDDaniel Dondorp
Daniel Dondorp
KFKari E Fladmark
Kari E Fladmark
DJ-1, a Parkinson's disease-associated protein, is strongly up-regulated in reactive astrocytes in Parkinson's disease. This is proposed to represent a neuronal protective response, although the mechanism has not yet been identified. We have generated a transgenic zebrafish line with increased astroglial DJ-1 expression driven by regulatory elements from the zebrafish GFAP gene. Larvae from this transgenic line are protected from oxidative stress-induced injuries as caused by MPP+, a mitochondrial complex I inhibitor shown to induce dopaminergic cells death. In a global label-free proteomics analysis of wild type and transgenic larvae exposed to MPP+, 3418 proteins were identified, in which 366 proteins were differentially regulated. In particular, we identified enzymes belonging to primary metabolism to be among proteins affected by MPP+ in wild type animals, but not affected in the transgenic line. Moreover, by performing protein profiling on isolated astrocytes we showed that an increase in astrocytic DJ-1 expression up-regulated a large group of proteins associated with redox regulation, inflammation and mitochondrial respiration. The majority of these proteins have also been shown to be regulated by Nrf2. These findings provide a mechanistic insight into the protective role of astroglial up-regulation of DJ-1 and show that our transgenic zebrafish line with astrocytic DJ-1 over-expression can serve as a useful animal model to understand astrocyte-regulated neuroprotection associated with oxidative stress-related neurodegenerative disease.

19 June 2019 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
AEAmanda J. Edson
Amanda J. Edson
HHHelena A. Hushagen
Helena A. Hushagen
AFAnn Kristin Frøyset
Ann Kristin Frøyset
IEInga Elda
Inga Elda
EKEssa A. Khan
Essa A. Khan
KFKari E Fladmark
Kari E Fladmark

1 May 2019 in Advances in Biological Regulation
Verified
Journal Article
Open access
RJRhîan G. Jacobsen
Rhîan G. Jacobsen
FGFatemeh Mazloumi Gavgani
Fatemeh Mazloumi Gavgani
AEAmanda J. Edson
Amanda J. Edson
MGMarianne Goris
Marianne Goris
AAAltanchimeg Altankhuyag
Altanchimeg Altankhuyag
ALAurelia Lewis
Aurelia Lewis
Biomolecular interactions between proteins and polyphosphoinositides (PPIn) are essential in the regulation of the vast majority of cellular processes. Consequently, alteration of these interactions is implicated in the development of many diseases. PPIn are phosphorylated derivatives of phosphatidylinositol and consist of seven species with different phosphate combinations. PPIn signal by recruiting proteins via canonical domains or short polybasic motifs. Although their actions are predominantly documented on cytoplasmic membranes, six of the seven PPIn are present within the nucleus together with the PPIn kinases, phosphatases and phospholipases that regulate their turnover. Importantly, the contribution of nuclear PPIn in the regulation of nuclear processes has led to an increased recognition of their importance compared to their more accepted cytoplasmic roles. This review summarises our knowledge on the identification and functional characterisation of nuclear PPIn-effector proteins as well as their mode of interactions, which tend to favour polybasic motifs.

1 April 2018 in Redox Biology
Verified
Journal Article
Open access
Javier EgeaJavier Egea
Javier Egea
IFI. Fabregat
I. Fabregat
YFY.M. Frapart
Y.M. Frapart
PGPietro Ghezzi
Pietro Ghezzi
AGA. Görlach
A. Görlach
Andreas DaiberAndreas Daiber
Andreas Daiber
The European Cooperation in Science and Technology (COST) provides an ideal framework to establish multi-disciplinary research networks. COST Action BM1203 (EU-ROS) represents a consortium of researchers from different disciplines who are dedicated to providing new insights and tools for better understanding redox biology and medicine and, in the long run, to finding new therapeutic strategies to target dysregulated redox processes in various diseases. This report highlights the major achievements of EU-ROS as well as research updates and new perspectives arising from its members. The EU-ROS consortium comprised more than 140 active members who worked together for four years on the topics briefly described below. The formation of reactive oxygen and nitrogen species (RONS) is an established hallmark of our aerobic environment and metabolism but RONS also act as messengers via redox regulation of essential cellular processes. The fact that many diseases have been found to be associated with oxidative stress established the theory of oxidative stress as a trigger of diseases that can be corrected by antioxidant therapy. However, while experimental studies support this thesis, clinical studies still generate controversial results, due to complex pathophysiology of oxidative stress in humans. For future improvement of antioxidant therapy and better understanding of redox-associated disease progression detailed knowledge on the sources and targets of RONS formation and discrimination of their detrimental or beneficial roles is required. In order to advance this important area of biology and medicine, highly synergistic approaches combining a variety of diverse and contrasting disciplines are needed

1 January 2020
Verified
Book Chapter
Closed access
AEAmanda J. Edson
Amanda J. Edson
HHHelena A. Hushagen
Helena A. Hushagen
KFKari E. Fladmark
Kari E. Fladmark